'inch'

If there is any merit to this merger why is price so low?

https://www.marketbeat.com/instant-alerts/nasdaq-lunr-boost-price-target-2024-02-23/

Back to reality

Volume looks like a bunch sold market when they saw the price. Price still shows $1.00 as last. Definitely seems like a glitch.

Dont get too excited

The AS are not maxed out they have room to issue an additional about 150m shares which is 30% of the company. Even so this would still be heavily undervalued but there is still room for some dilution here.

Also does anyone know about the restriction period for insiders to sell? Are they holding most of the OS because they have to or because they want to?

Yahoo shows almost no shares owned by insiders or institutions. Is that inaccurate? Is there a better source for me to see the actual figures?

Even with CDEL trying to hold it down the action doesn't make sense with the numbers they are projecting and the current price..

I can't help but feel there is more to the story and this is another EEENF waiting to happen. Sure hope Im wrong.

What am I missing? If this deal is worth $200m+ within 24 months and market cap is currently at $4m why is this not seriously taking off?

I assume there will be some dilution and more capital needs to be raised which of course will take away from the current shareholders value but even so that should leave plenty of room for current shares to run.

There must be more to the story that I am overlooking and can't find it. Any insight?

You can watch their moves here.

http://www.otcmarkets.com/stock/INNV/quote

Lol now that 3 of us nipped that argument in the bud.. Go back to daytona, paul.

Because thats, in essence, exactly what Novalere has done.. Once Fluticare is approved Novalere and Innovus effectively merge companies and Novalere becomes a 49% stakeholder in Innovus. Novelere themselves did not have the experience and know how to take this product to OTC so they did exactly what they should have and made a deal with a company/mgmt with experience so both could benefit from the synergies to come.

Here come some big bids!

Just doubled my position

They have a credit line, will easily be able to get regular non-convertible financing, and already have reserved shares set aside for production agreements once Fluticare is approved. If approval hits they're in pretty good shape, if it doesn't a reverse split is the least of my worries.

They still have shares to sell though. And besides re-issuing the same shares they would be taking off the market I don't see how a rs gives them more money. Not to mention with mgmt holding so many shares wouldn't that be the last thing they want to do to themselves? It would crush stock price after the split and any new dilution would just add more downward pressure. Lose, lose, lose as I see it. Not knocking your insight as I don't know any better in regards to a rs but I don't see how that makes sense for anyone.

Why would they do a reverse split?

Another thing to keep in mind is these diluted shares are worth .25 to all of these investors. Anything below that and they take a hit, so clearly they believe the shares are still worth more than .25 otherwise they would not have exercised any warrants.

.40 holding is big in terms of price action.

Just an fyi that is info recorded on the first of the month, not necessarily today's short interest. Those numbers haven't changed on that site all month.

How is there already volume/price change pre-market?

What a boring day.. Wake me up when something pops.

Ya idk who taught you how to value a company but you're talking about a $6 billion + market cap at that point.

That being said if Fluticare goes this is still worth 1.20 on a fully diluted basis. Until then though any dilution will play a significant role on current prices.

The S-1 stated the warrant holders can execute their warrants at any time prior to being paid back with a one day notice to the company. The warrants were initially offered at a premium with share price being lower than the offered strike price, so if a warrant holder chose to exercise those shares you better believe they were ready to offload them otherwise they would simply wait until the maturity date of their loan, see where price was at then, and choose to exercise the warrants or receive payment for their loans/interest. For any of them to exercise the shares in order to hold them makes no sense considering they can do so on any day. If they want to hold until price hits $1.00 say, they would just wait to exercise their options until price was at $1.00 and then do so. To exercise and hold puts them in a position of added risk effectively forfeiting their right to debt repayment with no guarantee pps will go up from current levels. All Im saying is short term, that dilution is never good. Of course Fluticare approval will offset the negative effects but until then 10m shares are sitting on 80% profit and I think they want to lock some of that in.

Check the quote on your broker page. Yesterday shares outstanding were mid 80m, yahoo finance still has it at 82m, and now its sitting at 96.6m via my broker. Im not BS'ing I've been an advocate for this stock the whole time Im just pointing out the change, clearly showing somebody exercised 10m shares worth of warrants and is likely now offloading for a profit.

Diluted by 10m shares so far. Shares outstanding is now 96m. So it starts.

Most people don't use wikipedia to get their prescription drug information.

Is there a but? lol.. Why invest in RNVA?

Nobody is sure. Odds are in our favor but nobody is sure otherwise he'd be selling his car to get more shares. Don't invest off a hot tip you hear on a message board.

Whats the hype on this stock about? Doesn't look crazy healthy, looks like it got beat up and people are hoping for any kind of bounce back to the kinds of prices it used to be worth? Insider buying at .28 is nice to see, warrants at .45 are not but that means the company has to exceed .45 significantly for those warrant holders to justifiably exercise those shares, so from current levels thats a good sign. Fundamentally speaking though is there some sort of break through everyone is waiting on for price to jump or is it more hoping for a bounce based on those other factors?

Why do you put approval at 60%? I have a hard time seeing denial considering the prior success of this drug and its reputation amongst patients and doctors alike. Curious to hear your view.

Bammmm bammm so the convertible debt everyone is freaking out about isn't even convertible until July 2017 and only if we can't repay them by then. Meaning if Fluticare is approved we don't have to worry about a bit of dilution. Also the Net Loss is in large part a translation of that same convertible debt compared to current price so assuming that debt gets paid off in time that "loss" is never realized on the bottom line. Gettin ready for a big day tomorrow!

Do we know when this 10-Q drops?

Market makers setting support.

25-30k shares bought at market will push us through .43 with the next MM resistance coming in at .53.

Citadel Securities just placed the bid 4 min ago.

They are selling and buying the same shares because they know approval is coming. Trying to shake retail investors out of their positions and pick up the same shares they sold for a few pennies less to lower their average fill price upon approval.

Ya that will likely scare some of the small time traders off if the approval process is dragged out too long but you hit the nail on the head. With current revenue, product line, and growth INNV is fairly valued at these levels. Regardless of what happens in the short term with people getting scared off mixed with some profit taking, smart long term investors will capitalize on any price dip and ultimately bring the price of shares back up. Thats why Im holding long and strong, if small scale investors get shook and drop the price and approval sends shares flying overnight, I refuse to miss out just because my position takes a short term hit from current levels. If you believe in the growth of INNV and that approval is coming, the most dangerous thing you could do right now is sell your shares in hopes of getting back in at a cheaper price. Some might get lucky, but I wouldn't count on it.

Moral of the story nobody realistically knows when approval/denial should come. Its up to the FDA and the FDA only, they will give their verdict when they are ready and no amount of predictions will change the FDA's timeframe.